Cargando…

Vicious LQT induced by a combination of factors different from hERG inhibition

Clinically, drug-induced torsades de pointes (TdP) are rare events, whereas the reduction of the human ether-à-go-go-related gene (hERG) current is common. In this study, we aimed to explore the specific factors that contribute to the deterioration of hERG inhibition into malignant ventricular arrhy...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xinping, Yin, Yue, Li, Dayan, Yao, Binwei, Zhao, Li, Wang, Haoyu, Wang, Hui, Dong, Ji, Zhang, Jing, Peng, Ruiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354841/
https://www.ncbi.nlm.nih.gov/pubmed/35935820
http://dx.doi.org/10.3389/fphar.2022.930831
_version_ 1784763160181342208
author Xu, Xinping
Yin, Yue
Li, Dayan
Yao, Binwei
Zhao, Li
Wang, Haoyu
Wang, Hui
Dong, Ji
Zhang, Jing
Peng, Ruiyun
author_facet Xu, Xinping
Yin, Yue
Li, Dayan
Yao, Binwei
Zhao, Li
Wang, Haoyu
Wang, Hui
Dong, Ji
Zhang, Jing
Peng, Ruiyun
author_sort Xu, Xinping
collection PubMed
description Clinically, drug-induced torsades de pointes (TdP) are rare events, whereas the reduction of the human ether-à-go-go-related gene (hERG) current is common. In this study, we aimed to explore the specific factors that contribute to the deterioration of hERG inhibition into malignant ventricular arrhythmias. Cisapride, a drug removed from the market because it caused long QT (LQT) syndrome and torsade de pointes (TdP), was used to induce hERG inhibition. The effects of cisapride on the hERG current were evaluated using a whole-cell patch clamp. Based on the dose-response curve of cisapride, models of its effects at different doses (10, 100, and 1,000 nM) on guinea pig heart in vitro were established. The effects of cisapride on electrocardiogram (ECG) signals and QT interval changes in the guinea pigs were then comprehensively evaluated by multi-channel electrical mapping and high-resolution fluorescence mapping, and changes in the action potential were simultaneously detected. Cisapride dose-dependently inhibited the hERG current with a half inhibitory concentration (IC50) of 32.63 ± 3.71 nM. The complete hERG suppression by a high dose of cisapride (1,000 nM) prolonged the action potential duration (APD), but not early after depolarizations (EADs) and TdP occurred. With 1 μM cisapride and lower Mg(2+)/K(+), the APD exhibited triangulation, dispersion, and instability. VT was induced in two of 12 guinea pig hearts. Furthermore, the combined administration of isoproterenol was not therapeutic and increased susceptibility to ventricular fibrillation (VF) development. hERG inhibition alone led to QT and ERP prolongation and exerted an anti-arrhythmic effect. However, after the combination with low concentrations of magnesium and potassium, the prolonged action potential became unstable, triangular, and dispersed, and VT was easy to induce. The combination of catecholamines shortened the APD, but triangulation and dispersion still existed. At this time, VF was easily induced and sustained.
format Online
Article
Text
id pubmed-9354841
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93548412022-08-06 Vicious LQT induced by a combination of factors different from hERG inhibition Xu, Xinping Yin, Yue Li, Dayan Yao, Binwei Zhao, Li Wang, Haoyu Wang, Hui Dong, Ji Zhang, Jing Peng, Ruiyun Front Pharmacol Pharmacology Clinically, drug-induced torsades de pointes (TdP) are rare events, whereas the reduction of the human ether-à-go-go-related gene (hERG) current is common. In this study, we aimed to explore the specific factors that contribute to the deterioration of hERG inhibition into malignant ventricular arrhythmias. Cisapride, a drug removed from the market because it caused long QT (LQT) syndrome and torsade de pointes (TdP), was used to induce hERG inhibition. The effects of cisapride on the hERG current were evaluated using a whole-cell patch clamp. Based on the dose-response curve of cisapride, models of its effects at different doses (10, 100, and 1,000 nM) on guinea pig heart in vitro were established. The effects of cisapride on electrocardiogram (ECG) signals and QT interval changes in the guinea pigs were then comprehensively evaluated by multi-channel electrical mapping and high-resolution fluorescence mapping, and changes in the action potential were simultaneously detected. Cisapride dose-dependently inhibited the hERG current with a half inhibitory concentration (IC50) of 32.63 ± 3.71 nM. The complete hERG suppression by a high dose of cisapride (1,000 nM) prolonged the action potential duration (APD), but not early after depolarizations (EADs) and TdP occurred. With 1 μM cisapride and lower Mg(2+)/K(+), the APD exhibited triangulation, dispersion, and instability. VT was induced in two of 12 guinea pig hearts. Furthermore, the combined administration of isoproterenol was not therapeutic and increased susceptibility to ventricular fibrillation (VF) development. hERG inhibition alone led to QT and ERP prolongation and exerted an anti-arrhythmic effect. However, after the combination with low concentrations of magnesium and potassium, the prolonged action potential became unstable, triangular, and dispersed, and VT was easy to induce. The combination of catecholamines shortened the APD, but triangulation and dispersion still existed. At this time, VF was easily induced and sustained. Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9354841/ /pubmed/35935820 http://dx.doi.org/10.3389/fphar.2022.930831 Text en Copyright © 2022 Xu, Yin, Li, Yao, Zhao, Wang, Wang, Dong, Zhang and Peng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Xu, Xinping
Yin, Yue
Li, Dayan
Yao, Binwei
Zhao, Li
Wang, Haoyu
Wang, Hui
Dong, Ji
Zhang, Jing
Peng, Ruiyun
Vicious LQT induced by a combination of factors different from hERG inhibition
title Vicious LQT induced by a combination of factors different from hERG inhibition
title_full Vicious LQT induced by a combination of factors different from hERG inhibition
title_fullStr Vicious LQT induced by a combination of factors different from hERG inhibition
title_full_unstemmed Vicious LQT induced by a combination of factors different from hERG inhibition
title_short Vicious LQT induced by a combination of factors different from hERG inhibition
title_sort vicious lqt induced by a combination of factors different from herg inhibition
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354841/
https://www.ncbi.nlm.nih.gov/pubmed/35935820
http://dx.doi.org/10.3389/fphar.2022.930831
work_keys_str_mv AT xuxinping viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT yinyue viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT lidayan viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT yaobinwei viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT zhaoli viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT wanghaoyu viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT wanghui viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT dongji viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT zhangjing viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition
AT pengruiyun viciouslqtinducedbyacombinationoffactorsdifferentfromherginhibition